Back to Search Start Over

Determinants of cervical cancer screening among women living with HIV in Zimbabwe.

Authors :
Antabe, Roger
Luginaah, Nasong A
Kangmennaang, Joseph
Mkandawire, Paul
Source :
Health Promotion International. Aug2023, Vol. 38 Issue 4, p1-12. 12p.
Publication Year :
2023

Abstract

In sub-Saharan Africa (SSA), cervical cancer (CC) is the second leading cause of cancer-related deaths, with human immunodeficiency virus (HIV) seropositive women being particularly vulnerable. Despite the benefits of early CC screening in reducing HIV-related CC deaths, CC screening uptake remains limited, with wide disparities in access across SSA. As part of a larger study, this paper examines the determinants of CC screening among HIV-seropositive women of reproductive age (15–49 years) in Zimbabwe. Using the 2015 Zimbabwe Demographic and Health Survey, we conducted multilevel analyses of CC screening among 1490 HIV-seropositive women, nested in 400 clusters. Our findings revealed that, even though 74% of HIV-seropositive women knew about CC, only 17.6% of them reported ever screening for it. Women who held misconceptions about HIV (OR = 0.47, p = 0.01) were less likely to screen for CC compared to those with accurate knowledge about HIV and CC. HIV-seropositive women with secondary or higher education were more likely to screen (OR = 1.39, p = 0.04) for CC compared to those with a primary or lower level of education. Age was positively associated with screening for CC. Furthermore, locational factors, including province and rural–urban residence, were associated with CC screening. Based on these findings, we call for integrated care and management of HIV and non-communicable diseases in Southern Africa, specifically, Zimbabwe due to the legacy of HIV in the region. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
09574824
Volume :
38
Issue :
4
Database :
Academic Search Index
Journal :
Health Promotion International
Publication Type :
Academic Journal
Accession number :
171352564
Full Text :
https://doi.org/10.1093/heapro/daad073